moxisylyte   Click here for help

GtoPdb Ligand ID: 12306

Synonyms: Opilon® | thymoxamine
Approved drug
moxisylyte is an approved drug
Compound class: Synthetic organic
Comment: Moxisylyte is an antagonist of α1 adrenoceptors, with some selectivity for the α1A subtype [2]. It improves blood circulation to the extremities and has been used to treat primary Raynaud's syndrome .
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 0
Rotatable bonds 7
Topological polar surface area 38.77
Molecular weight 279.18
XLogP 2.99
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(CCOc1cc(C)c(cc1C(C)C)OC(=O)C)C
Isomeric SMILES Cc1cc(c(cc1OC(=O)C)C(C)C)OCCN(C)C
InChI InChI=1S/C16H25NO3/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6/h9-11H,7-8H2,1-6H3
InChI Key VRYMTAVOXVTQEF-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
The BNF entry for moxisylyte indicates it for the short-term treatment of primary Raynaud's syndrome, but no licensed medicines are listed on that webpage. However this drug is no longer catalogued by the eMC so it is unclear if it is still in clinical use in the UK.